Accessibility settings

This paper is in the following e-collection/theme issue:

Cancer Prognosis Models and Machine Learning (142) Cancer Survivorship (458) Secondary Use of Clinical Data for Research and Surveillance (650) Precision Medicine (453) Innovations in Cancer Diagnostic and Decision Support (158)

Published on in Vol 12 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73576, first published .
Gloved hands, one holding virus models, the other holding red and white capsules.

Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study

Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study

Authors of this article:

Baidong Zhang1 Author Orcid Image ;   Zhichao Kang1 Author Orcid Image ;   Yi Ding1 Author Orcid Image ;   Wang Jing1 Author Orcid Image ;   Alei Feng1 Author Orcid Image ;   Renya Zeng1 Author Orcid Image ;   Jianan Li1 Author Orcid Image ;   Yi Zhao1 Author Orcid Image ;   Yuanliu Nie2 Author Orcid Image ;   Wentao Zhang2 Author Orcid Image ;   Lu Sun1 Author Orcid Image ;   Zhe Yang1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Yu J, Cui Y, Li S, Guo X, Li N, Gu Y, Jin Y, Chen Y, Li X, Yan Y, Wu Z, Zhu C, Feng L. The Lactate–Lactylation Axis as a Metabolic–Epigenetic Framework for Therapeutic Adaptation in Esophageal Squamous Cell Carcinoma. Cancers 2026;18(18):2991 View